phrykt

AbbVie (ABBV) revenue: $61.2B

AbbVie reported $61.2B of revenue for the year ended Dec 31, 2025, up 8.6% from $56.3B a year earlier.

From AbbVie's filings with the SEC · Read the filing · ABBV stock page

AbbVie revenue by year

$56.2B2021$58.1B2022$54.3B2023$56.3B2024$61.2B2025

#74 of 3,623 US companies by revenue · See the full ranking

Year endedRevenueChange
Dec 31, 2025$61.2B+9%
Dec 31, 2024$56.3B+4%
Dec 31, 2023$54.3B-6%
Dec 31, 2022$58.1B+3%
Dec 31, 2021$56.2B–

Revenue of similar companies

Companies in the same industry as AbbVie, by SEC industry code, with the closest revenue. Each name opens the same page for that company.

CompanyRevenue, latest yearYear ended
Johnson & Johnson$94.2BDec 28, 2025
Eli Lilly$65.2BDec 31, 2025
Merck$65BDec 31, 2025
Pfizer$62.6BDec 31, 2025
AbbVie$61.2BDec 31, 2025
Bristol Myers Squibb$48.2BDec 31, 2025
Abbott Laboratories$44.3BDec 31, 2025

Questions and answers

What is AbbVie's revenue?

AbbVie reported $61.2B of revenue for the year ended Dec 31, 2025, up 8.6% from $56.3B a year earlier.

Numbers as reported in AbbVie's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology